Company Profile

TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. The Companyâ€™s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Companyâ€™s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Employees

592

Sector

Pharmaceuticals

More about the company

02-27	Shionogi & Co., Ltd. and Torii Pharmaceutical Co., Ltd. Announce the Submission of an Application for Manufacturing and Marketing Approval for A 0.5% Lotion Formulation of the Atopic Dermatitis Treatment Corectim	CI
02-09	Verrica Pharmaceuticals Announces Launch of YCANTH for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical	CI
19/09/25	Torii Pharmaceutical Co. Ltd. Receives Approval for YCANTH (TO-208) in Japan for the Treatment of Molluscum Contagiosum	CI
31/08/25	Torii Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 7, 2025, has expired.	CI
10/07/25	Torii Pharmaceutical Co Ltd says it will retire treasury shares worth 2.39% of outstanding stock on Aug 29	RE
01/07/25	Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH for the Treatment of Common Warts	CI
30/06/25	Torii Pharmaceutical Co., Ltd.(TSE:4551) dropped from S&P Global BMI Index	CI
19/06/25	Shionogi Completes Tender Offer for Torii Pharmaceutical, Acquiring 39% Stake	MT
17/06/25	Shionogi & Co., Ltd. completed the acquisition of 44.1% stake in Torii Pharmaceutical Co., Ltd. from group of sellers.	CI
08/05/25	Japan's Nikkei ends higher; NTT Data surges on takeover report	RE
08/05/25	Japan's Nikkei rises; NTT Data set to surge on takeover report	RE
07/05/25	Shionogi to Acquire Japan Tobacco's Pharma Business, Take Full Control of Torii Pharmaceutical	MT
07/05/25	Deals of the day-Mergers and acquisitions	RE

19/09/25	Verrica Pharmaceuticals secures USD10m milestone payment following Japanese approval of YCANTH	AQ
27/08/25	Torii Pharmaceutical : Announcement of Delisting of Company Stock（PDF）	PU
19/06/25	Torii Pharmaceutical : Announcement of Results of the Tender Offer for Our Shares by Shionogi & Co., Ltd. and Changes in an Other Associated Company and a Major Shareholder（PDF）	PU
05/06/25	Torii Pharmaceutical : (Amendment) Partial amendments to the “Announcement of Expression of Opinion in Support of the Tender Offer for Our Shares by Shionogi & Co., Ltd. and Recommendation to Tender Shares in the Tender Offer”（PDF）	PU
05/06/25	Torii Pharmaceutical : Our Relationship with Patent Infringement Lawsuit regarding Drug Use Patent Pertaining to Oral Antipruritus Medication “REMITCH ® ” announced by Toray Industries, Inc. on May 27, 2025（PDF）	PU

07/05/25	Bourse : Veolia, Legrand, Novo, BAE pour les publications, nominations chez Kering et Alstom
07/05/25	La Chine et les Etats-Unis vont se parler
31/07/19	Japan Tobacco: la rentabilité s'essouffle au 2e trimestre, minée par les changes

Manager	Title	Age	Since
Yukihiro Takashima DFI	Director of Finance/CFO	-	-
Megumi Kajiwara CTO	Chief Tech/Sci/R&D Officer	-	-
Masaki Sunami PRN	Corporate Officer/Principal	67	31/03/2014

Director	Title	Age	Since
Mihoko Manabe BRD	Director/Board Member	67	26/03/2024
Kenichi Fujita BRD	Director/Board Member	67	26/03/2024

Torii Pharmaceutical Co., Ltd. Share Price

Equities

4551

JP3635800000

Pharmaceuticals

Chart: Torii Pharmaceutical Co., Ltd.

Latest news: Torii Pharmaceutical Co., Ltd.

Press Releases: Torii Pharmaceutical Co., Ltd.

News in other languages: Torii Pharmaceutical Co., Ltd.

Quotes and Performance

Managers and Directors: Torii Pharmaceutical Co., Ltd.

ETFs: Torii Pharmaceutical Co., Ltd.

Other Pharmaceuticals

Company Profile

Name	Varia. Jan 1.	Weight	AuM
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY	+8.33%	0.12%	29 M€
NZAM ETF TOPIX EX-FINANCIALS - JPY	+4.06%	0.01%	19 M€
MAXIS TOPIX ETF - JPY	+8.19%	0.01%	22,608 M€

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
TORII PHARMACEUTICAL CO., LTD.	+0.32%	+0.32%	-	-	1.13B
ELI LILLY AND COMPANY	+0.72%	-5.86%	+8.50%	+210.49%	885B
JOHNSON & JOHNSON	+0.32%	-3.23%	+44.97%	+54.54%	579B
ABBVIE INC.	-0.96%	-0.85%	+9.19%	+48.19%	407B
ROCHE HOLDING AG	-2.93%	-7.03%	+12.72%	+26.04%	350B
NOVARTIS AG	-1.25%	-5.55%	+23.92%	+55.59%	302B
ASTRAZENECA PLC	-1.85%	-6.70%	+20.55%	+34.98%	301B
MERCK & CO., INC.	-0.24%	-6.49%	+23.18%	+4.22%	286B
AMGEN INC.	+0.53%	-4.80%	+16.27%	+57.17%	199B
GILEAD SCIENCES, INC.	-0.83%	-3.37%	+24.03%	+77.45%	179B
Average	-0.62%	-4.69%	+20.37%	+63.19%	387.64B
Weighted average by Cap.	-0.47%	-4.59%	+19.88%	+86.08%